Statements this site makes, each with the source behind it.
Current EASL-EASD-EASO guidance recommends improving diet quality in a pattern similar to a Mediterranean dietary pattern, limiting ultra-processed foods rich in sugars and saturated fat, and avoiding sugar-sweetened beverages for adults with MASLD.
How we use it: This describes a dietary pattern, not a list of curative foods. The site does not claim that a recipe reverses fibrosis or replaces medical management.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c01
AASLD guidance links excess saturated fat, refined carbohydrate and sugar-sweetened beverages with NAFLD/MASLD risk and supports dietary patterns that favour higher fibre and unsaturated fats.
How we use it: Associations and dietary guidance do not justify a single rigid macronutrient ratio for every reader.
Sources: AASLD Practice Guidance on the clinical assessment and management of NAFLD/MASLD · Eating, Diet, & Nutrition for NAFLD & NASH
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c02
For adults with MASLD and overweight, current EASL guidance recommends sustained weight reduction, with different ranges associated with reductions in liver fat, inflammation and fibrosis.
How we use it: These targets apply in a defined clinical/weight context. The recipe site does not prescribe weight loss, calorie deficits or target weights to all readers.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c03
Normal-weight adults can also have MASLD, and current EASL guidance recommends diet and exercise interventions to reduce liver fat without making weight loss a universal requirement.
How we use it: Body size alone does not diagnose MASLD and should not be used by the site to infer who has the condition.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD · Diagnosis of NAFLD & NASH
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c04
Doctors diagnose and assess MASLD using medical history, examination and tests; diet response or body weight alone cannot establish diagnosis or fibrosis stage.
How we use it: The site does not interpret liver enzymes, FIB-4, imaging or other tests and does not distinguish MASL from MASH for an individual.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD · Diagnosis of NAFLD & NASH
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c05
Current EASL guidance does not recommend nutraceuticals for MASLD because evidence of effectiveness and safety is insufficient.
How we use it: A food site should not market supplements, herbal products, detoxes or cleanses as liver treatment.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c06
Dietary patterns can be adapted to culture and preference; Mediterranean-style guidance describes food-pattern characteristics rather than requiring Mediterranean cuisine at every meal.
How we use it: The site can translate the pattern into globally available foods without claiming cultural equivalence or one mandatory cuisine.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD · AASLD Practice Guidance on the clinical assessment and management of NAFLD/MASLD
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c07
Alcohol is a relevant clinical factor in fatty-liver assessment and current guidance discourages alcohol consumption in MASLD, with stricter advice in advanced fibrosis/cirrhosis.
How we use it: The site does not set a personal safe alcohol allowance or use alcohol intake to diagnose the cause or stage of liver disease.
Sources: EASL–EASD–EASO Clinical Practice Guidelines on MASLD · Diagnosis of NAFLD & NASH
Cite this claim: https://cernere.xyz/conditions/masld-fatty-liver/evidence/#ma-c08
